Tatjana Gazibara1,2, Lau Caspar Thygesen1, Maria Holst Algren1, Janne Schurmann Tolstrup3. 1. National Institute of Public Health, University of Southern Denmark, Copenhagen K, Denmark. 2. Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Visegradska 26A, Belgrade, 11000, Serbia. 3. National Institute of Public Health, University of Southern Denmark, Copenhagen K, Denmark. jest@sdu.dk.
Abstract
BACKGROUND: Previous studies have not explored the effect of HPV vaccination on health status at a longer time interval. Similarly, self-reported physical and mental health in recipients of the HPV vaccine has not been studied. OBJECTIVE: To evaluate whether HPV vaccination was associated with physical and mental health complaints among girls in secondary education institutions. DESIGN: Prospective cohort study. PARTICIPANTS: This study used data from girls aged 15-20 years who participated in the Danish National Youth Study (DNYS) 2014. Data on HPV vaccination was retrieved from the Danish Vaccination Register. MAIN MEASURES: Participants were asked whether they had experienced headaches, stomachache, neck pain, menstrual cramps, sore throat, sadness, irritation, nervousness and sleep problems in the past 6 months. KEY RESULTS: Of 41,333 girls, 39,145 (94.7%) received at least one dose of HPV vaccine. The most prevalent health complaint among the vaccinated and not vaccinated females was "been irritable" (88.2% and 88.4%, respectively). The lowest proportion of health complaints was stomachache (49.6% in vaccinated and in 50.4% in unvaccinated girls). Regression model, adjusted for socio-demographic characteristics and health behavior, showed that HPV vaccination was associated with a lower likelihood of reporting sore throat (odd ratio [OR] 0.86, 95% confidence interval [CI] 0.78-0.95) and being sad (OR 0.86, 95%CI 0.76-0.97). Similar results were observed when HPV vaccination status was analyzed according to the number of doses received. CONCLUSION: We conclude that HPV vaccination was not associated with physical and mental health complaints among girls in secondary education institutions in Denmark after a median of 5.3 years since HPV vaccination.
BACKGROUND: Previous studies have not explored the effect of HPV vaccination on health status at a longer time interval. Similarly, self-reported physical and mental health in recipients of the HPV vaccine has not been studied. OBJECTIVE: To evaluate whether HPV vaccination was associated with physical and mental health complaints among girls in secondary education institutions. DESIGN: Prospective cohort study. PARTICIPANTS: This study used data from girls aged 15-20 years who participated in the Danish National Youth Study (DNYS) 2014. Data on HPV vaccination was retrieved from the Danish Vaccination Register. MAIN MEASURES: Participants were asked whether they had experienced headaches, stomachache, neck pain, menstrual cramps, sore throat, sadness, irritation, nervousness and sleep problems in the past 6 months. KEY RESULTS: Of 41,333 girls, 39,145 (94.7%) received at least one dose of HPV vaccine. The most prevalent health complaint among the vaccinated and not vaccinated females was "been irritable" (88.2% and 88.4%, respectively). The lowest proportion of health complaints was stomachache (49.6% in vaccinated and in 50.4% in unvaccinated girls). Regression model, adjusted for socio-demographic characteristics and health behavior, showed that HPV vaccination was associated with a lower likelihood of reporting sore throat (odd ratio [OR] 0.86, 95% confidence interval [CI] 0.78-0.95) and being sad (OR 0.86, 95%CI 0.76-0.97). Similar results were observed when HPV vaccination status was analyzed according to the number of doses received. CONCLUSION: We conclude that HPV vaccination was not associated with physical and mental health complaints among girls in secondary education institutions in Denmark after a median of 5.3 years since HPV vaccination.
Entities:
Keywords:
HPV vaccination; girls; health status; secondary education institutions
Authors: T M Schurink-Van't Klooster; J M Kemmeren; N A T van der Maas; E M van de Putte; M Ter Wolbeek; S L Nijhof; A M Vanrolleghem; J A van Vliet; M Sturkenboom; H E de Melker Journal: Vaccine Date: 2018-09-24 Impact factor: 3.641
Authors: Marc Brisson; Jean-François Laprise; Mélanie Drolet; Nicolas Van de Velde; Eduardo L Franco; Erich V Kliewer; Gina Ogilvie; Shelley L Deeks; Marie-Claude Boily Journal: Vaccine Date: 2013-07-03 Impact factor: 3.641
Authors: Nikolai M Scheller; Björn Pasternak; Ditte Mølgaard-Nielsen; Henrik Svanström; Anders Hviid Journal: N Engl J Med Date: 2017-03-30 Impact factor: 91.245